4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-10-000044
Chairman/CEO/President bought 26,000 shares at an average $0.21 ($5,450)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · Chairman/CEO/President
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2010-10-27 | Purchase : show line 1 in the form | +10,000 | $0.20 | $2,000 | 1,182,986 | D |
| 2010-10-27 | Purchase : show line 2 in the form | +5,000 | $0.25 | $1,250 | 1,187,986 | D |
| 2010-10-28 | Purchase : show line 3 in the form | +11,000 | $0.20 | $2,200 | 1,198,986 | D |
| Open-market purchases · 26,000 sh · avg $0.21 · $5,450 | ||||||
Loading xslF345X03/primary_doc.xml…